Department of Genetics, University of Valencia, Burjassot (Valencia), Spain.
Appl Environ Microbiol. 2012 Aug;78(16):5690-8. doi: 10.1128/AEM.00523-12. Epub 2012 Jun 8.
Resistance to Bacillus thuringiensis Cry1Ac toxin was characterized in a population of Helicoverpa zea larvae previously shown not to have an alteration in toxin binding as the primary resistance mechanism to this toxin. Cry1Ac-selected larvae (AR1) were resistant to protoxins and toxins of Cry1Ab, Cry1Ac, and the corresponding modified proteins lacking helix α-1 (Cry1AbMod and Cry1AcMod). When comparing brush border membrane vesicles (BBMVs) prepared from susceptible (LC) and AR1 larval midguts, there were only negligible differences in overall Cry1Ac toxin binding, though AR1 had 18% reversible binding, in contrast to LC, in which all binding was irreversible. However, no differences were detected in Cry1Ac-induced pore formation activity in BBMVs from both strains. Enzymatic activities of two putative Cry1Ac receptors (aminopeptidase N [APN] and alkaline phosphatase [ALP]) were significantly reduced (2-fold and 3-fold, respectively) in BBMVs from AR1 compared to LC larvae. These reductions corresponded to reduced protein levels in midgut luminal contents only in the case of ALP, with an almost 10-fold increase in specific ALP activity in midgut fluids from AR1 compared to LC larvae. Partially purified H. zea ALP bound Cry1Ac toxin in ligand blots and competed with Cry1Ac toxin for BBMV binding. Based on these results, we suggest the existence of at least one mechanism of resistance to Cry1A toxins in H. zea involving binding of Cry1Ac toxin to an ALP receptor in the larval midgut lumen of resistant larvae.
棉铃虫幼虫对苏云金芽孢杆菌 Cry1Ac 毒素的抗性特征在于,先前已证明该幼虫对该毒素的主要抗性机制不是改变毒素结合。Cry1Ac 选择的幼虫(AR1)对 protoxins 和 Cry1Ab、Cry1Ac 及其相应缺失螺旋 α-1 的修饰蛋白(Cry1AbMod 和 Cry1AcMod)的毒素具有抗性。当比较来自敏感(LC)和 AR1 幼虫中肠的刷状缘膜囊泡(BBMV)时,尽管 AR1 的可逆结合为 18%,而 LC 的所有结合均为不可逆,但总体 Cry1Ac 毒素结合仅存在可忽略的差异。然而,在两种菌株的 BBMVs 中,均未检测到 Cry1Ac 诱导的孔形成活性的差异。两个假定的 Cry1Ac 受体(氨肽酶 N [APN]和碱性磷酸酶 [ALP])的酶活性在 AR1 的 BBMVs 中均显著降低(分别降低 2 倍和 3 倍)与 LC 幼虫相比。在 ALP 的情况下,这种降低仅对应于中肠腔内容物中蛋白质水平的降低,而在 AR1 中肠液中的特异性 ALP 活性几乎增加了 10 倍与 LC 幼虫相比。部分纯化的 H. zea ALP 在配体印迹中结合 Cry1Ac 毒素,并与 BBMV 结合竞争 Cry1Ac 毒素。基于这些结果,我们建议在 H. zea 中存在至少一种 Cry1A 毒素抗性机制,涉及 Cry1Ac 毒素与抗性幼虫中肠腔中 ALP 受体的结合。